Showing results (1421-1430 of 1,611) with videos related to
Sort By:
Pageof 162
JAMA Oncology|May 24, 2019
Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer: A Phase 2 Randomized Clinical TrialThomas B Karasic, Mark H O'Hara, Arturo Loaiza-Bonilla, et al.JAMA Oncology|April 19, 2019
Use of Crowd Innovation to Develop an Artificial Intelligence-Based Solution for Radiation Therapy TargetingRaymond H Mak, Michael G Endres, Jin H Paik, et al.JAMA Oncology|April 19, 2019
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical TrialRachna T Shroff, Milind M Javle, Lianchun Xiao, et al.JAMA Oncology|September 8, 2018
Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical TrialAman U Buzdar, Vera J Suman, Funda Meric-Bernstam, et al.JAMA Oncology|July 14, 2018
Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia RelapseMohamed A Kharfan-Dabaja, Myriam Labopin, Emmanuelle Polge, et al.JAMA Oncology|July 14, 2018
Surgeon Attitudes Toward the Omission of Axillary Dissection in Early Breast CancerMonica Morrow, Reshma Jagsi, M Chandler McLeod, et al.JAMA Oncology|May 17, 2019
Insights Into Breast Cancer in the East vs the West: A ReviewYoon-Sim Yap, Yen-Shen Lu, Kenji Tamura, et al.JAMA Oncology|May 3, 2019
Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell CarcinomaCarole Fakhry, Amanda L Blackford, Geoff Neuner, et al.JAMA Oncology|March 10, 2022
Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in FloridaAnna R Giuliano, Jeffrey E Lancet, Shari Pilon-Thomas, et al.JAMA Oncology|March 10, 2022
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised PatientsMichel Obeid, Madeleine Suffiotti, Celine Pellaton, et al.Pageof 162